These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5682446)

  • 1. Transplantation immunity and the suppression of spleen colony formation by immunization with murine leukemia virus preparations (Friend).
    Friend C; Rossi GB
    Int J Cancer; 1968 Jul; 3(4):523-9. PubMed ID: 5682446
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of Friend-associated lymphatic leukemia virus in immunization against Friend leukemia complex.
    Bendinelli M
    Experientia; 1977 Apr; 33(4):455-6. PubMed ID: 862726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of transplantation antigens in Friend viral leukemia.
    Oboshi S; Itakura K; Maruyama K
    Gan; 1967 Aug; 58(4):367-76. PubMed ID: 6082618
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenetic analysis of the mechanism of induction of Friend virus leukemia.
    Eckner RJ; Kumar V; Bennett M
    Transplant Proc; 1975 Jun; 7(2):173-84. PubMed ID: 236610
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival of mouse skin isografts from leukemic donors.
    Meeker WR; Mirand EA; Grace JT
    J Surg Oncol; 1969; 1(1):19-22. PubMed ID: 4939633
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of established Friend virus leukemia by statolon. V. Reversal of virus-induced immunodepression to sheep erythrocytes.
    Weislow OS; Friedman H; Wheelock EF
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):401-5. PubMed ID: 4570037
    [No Abstract]   [Full Text] [Related]  

  • 7. Passive and active immunity to Friend virus disease.
    Mirand EA; Grace JT; Buffett RF
    Nature; 1966 Feb; 209(5024):696-8. PubMed ID: 5922129
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutralization kinetics of friend and Rauscher leukemia viruses studied with the spleen focus assay method.
    Steeves RA; Axelrad AA
    Int J Cancer; 1967 May; 2(3):235-44. PubMed ID: 6041991
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance to Friend leukemia virus in mice: effect of immunosuppression.
    Stutman O; Dupuy JM
    J Natl Cancer Inst; 1972 Nov; 49(5):1283-93. PubMed ID: 4405498
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of host mechanisms involved in suppression of established Friend virus leukemia.
    Wheelock EF
    Bibl Haematol; 1975 Oct; (43):508-10. PubMed ID: 1067088
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 12. Are the neoantigens induced by leukemogenic viruses particular to cancer cells?
    Mathé G
    Bibl Haematol; 1968; 30():43-7. PubMed ID: 4877327
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protection of mice against Friend leukemia by active and passive immunization with isolated viral glycoprotein and its antiserum respectively (author's transl)].
    Hunsmann G; Moennig V; Seifert E; Schäfer W
    Z Naturforsch C Biosci; 1975; 30(2):309-10. PubMed ID: 125981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of the co-existance of Friend virus in "Friend tumour".
    Kobayashi H; Kodama T; Itoh T
    Nature; 1966 Nov; 212(5065):939-40. PubMed ID: 6003736
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic aspects of resistance to Friend leukemia virus.
    Franker CK; Quilligan JJ
    Proc Soc Exp Biol Med; 1966 Apr; 121(4):1090-3. PubMed ID: 5937708
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible splenomegaly with low virus production induced in hyperimmune mice by parabiosis with Friend-virus-infected mice.
    Takizawa K; Yoshikura H; Sugano H; Yamamoto T
    Int J Cancer; 1973 Sep; 12(2):502-10. PubMed ID: 4799699
    [No Abstract]   [Full Text] [Related]  

  • 17. Defect in cellular immunity of leukemia virus-infected mice assessed by a macrophage migration-inhibition assay.
    Friedman H; Ceglowski WS
    Proc Soc Exp Biol Med; 1971 Jan; 136(1):154-8. PubMed ID: 5540598
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy in Friend virus leukemia. II. Prevention of friend leukemia by passive administration of immune serum and cells to young mice.
    Wahren B
    J Natl Cancer Inst; 1968 Oct; 41(4):931-8. PubMed ID: 5693664
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of some of the biological properties of Friend virus and its pseudotypes.
    Dawson PJ; Fieldsteel AH
    Int J Cancer; 1973 Mar; 11(2):484-93. PubMed ID: 4597858
    [No Abstract]   [Full Text] [Related]  

  • 20. Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus.
    Ruan KS; Lilly F
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12202-6. PubMed ID: 1465459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.